Related Experiment Video
Updated: Jul 3, 2026
09:43
Multimodal Study of Murine Cardiovascular Remodeling: Four-Dimensional Ultrasound and Mass Spectrometry Imaging
Published on: January 10, 2025
Multimodality nanotracers for cardiovascular applications.
Willem J M Mulder1, David P Cormode, Sjoerd Hak
1Sinai Translational and Molecular Imaging Institute and Imaging Science Laboratories, Mount Sinai School of Medicine, One Gustave L Levy Place, New York, NY 10029, USA. willem.mulder@mountsinai.org
Nature Clinical Practice. Cardiovascular Medicine
|July 25, 2008
Summary
Multimodality nanoparticles offer targeted imaging and therapeutics for cardiovascular disease, aiding early diagnosis and improved treatment strategies. This approach enhances understanding of disease pathology and therapeutic efficacy.
Area of Science:
- Biomedical Engineering
- Cardiovascular Medicine
- Nanotechnology
Background:
- Targeted imaging and therapeutics are crucial for advancing cardiovascular disease (CVD) study and treatment.
- Current approaches aim for early diagnosis, better pathology understanding, and improved therapeutic efficacy.
- In vivo imaging of macrophages, vascular cell adhesion molecule 1, and alpha(v)beta(3) integrin are key areas of focus.
Purpose of the Study:
- To discuss the concept of multimodality nanoparticles for medical applications.
- To explore the clinical applications of these nanoparticles in molecular imaging and therapy.
- To present examples of cardiovascular applications, including combined imaging and therapy.
Main Methods:
- Review of general concepts of multimodality nanoparticles.
- In-depth focus on clinical applications for molecular imaging and therapy.
- Discussion of specific cardiovascular applications and combined approaches.
Main Results:
- Multimodality nanoparticles enable in vivo imaging of various cardiovascular targets.
- These agents facilitate molecular imaging and targeted therapeutic delivery.
- Combined imaging and therapy approaches show promise for cardiovascular disease management.
Conclusions:
- Multimodality nanoparticles represent a significant advancement in cardiovascular disease diagnosis and treatment.
- Their application in molecular imaging and targeted therapy offers improved efficacy and understanding of pathology.
- Further development and application in combined approaches are expected to enhance patient outcomes.
